Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications (Q57589658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

title

Direct medical cost of managing deep vein thrombosis according to the occurrence of complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Judith A O'Brien

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

603-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12141888 AND SRC:MED&resulttype=core&format=json

Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Heparin-Induced thrombocytopenia: minimising the risks in the elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

The use of automated data to identify complications and comorbidities of diabetes: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/00019053-200220090-00004

Antigens involved in heparin-induced thrombocytopenia.

21 January 2018

1 reference

12 December 2020

Pharmacy-managed program for home treatment of deep vein thrombosis with enoxaparin

1 reference

12 December 2020

Nursing Home Residents: A Multiwiate Analysis of Their Medical, Behavioral, Psychosocial, and Service Use Characteristics

1 reference

12 December 2020

How accurate are hospital discharge data for evaluating effectiveness of care?

1 reference

12 December 2020

Outpatient deep vein thrombosis treatment models

1 reference

12 December 2020

How to use low-molecular weight heparin for outpatient management of deep vein thrombosis

1 reference

12 December 2020

Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolism

1 reference

12 December 2020

Low-molecular-weight heparin in outpatient treatment of DVT.

1 reference

12 December 2020

Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program

1 reference

12 December 2020

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective

1 reference

12 December 2020

1 reference

12 December 2020

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group

1 reference

12 December 2020

Ambulatory care for ambulant patients with deep vein thrombosis

1 reference

12 December 2020